Your resource
Let's grab a virtual cup of coffee and talk about how to navigate the pharmacy market and make sure you're getting the best value. Or get in touch with us here to get together over a real cup!
Webinar
For self-insured employers, the talk about “potential” lawsuits is over – it’s here, and we’re all at risk. Please find below a webinar exploring the implications for fiduciaries of the recent lawsuit against J&J.
The suit claims Johnson & Johnson breached its fiduciary duty by failing to prudently manage its pharmacy benefit. Essentially, they traded control of their formulary for “guarantees” from conflicted entities.
We’re honored to be partnering with Chris Deacon, JD, healthcare thought leader and former director of one of the largest self-funded health plans in the country for the State of New Jersey.
In this webinar, you will learn:
What the lawsuit is alleging
What this means for self-insured employers
Concrete steps you can do today to understanding your risk and exposure
How utilizing Comparative Effectiveness Research drives clinical value and reduces costs
Insights
Our mission is to bring the best clinical data into the discussion about pharmacy costs and value. Explore our content for insights to help you understand how the market works, and strategies that make the market work for you.
Your rebate is not worth as much as you think
The Story of the "Little Blue Pill"
By Bethany Sneathen and Dr. James Stahl
Single payer? What we need is an informed payer.
By Catalina Gorla
Are PBMs still middlemen?
By Catalina Gorla
What do physicians think FDA approval means?
By Catalina Gorla
Case Studies
The proof is in the pudding, as they say. Learn how we have helped clients achieve significant savings with minimal effort and impact to their members and patients.
Pharmacy is a volume-based business: compare your company's size with those of our clients to estimate what the savings could be for you. Or send us a short note here and let us give you a firmer estimate.
Health System
Accountable care organization
Logistics Broker
Global customer experiences management services
city government
Public sector
WHITE PAPERS
Click on the papers below to learn more about our use of Comparative Effectiveness Research and how it compares to the FDA’s drug approval process.
